An adapted health system access framework for avoidable inflammatory bowel disease admissions: a scoping review [0.03%]
一项关于避免炎症性肠病住院的适应型卫生系统准入框架的综述研究
Rachel L Hawkins,Kimberly Butler,Fiona C Sampson et al.
Rachel L Hawkins et al.
Background: Access to healthcare may be driving unplanned and potentially avoidable hospital admissions for people diagnosed with inflammatory bowel disease (IBD). Interventions to reduce unplanned and potentially avoidab...
Confirming the association of ulcerative colitis with interstitial lung disease: a retrospective analysis of comorbid disease, demographics, and healthcare utilization [0.03%]
溃疡性结肠炎与间质性肺疾病关联性的确认：共病、人口统计学和医疗保健利用的回顾性分析
Sneh Parekh,Landen Shane Burstiner,Kaitlyn Romero et al.
Sneh Parekh et al.
Background: Interstitial lung disease (ILD) is a rare extraintestinal manifestation associated with inflammatory bowel disease (IBD). Limited information is available regarding the prevalence and risk factors of ILD in IB...
Ileocecal resection for primary Crohn's disease: a 17-year experience from a tertiary care hospital in North Africa [0.03%]
北非一家三级护理医院17年间原发性克罗恩病回盲部切除术的经验
Souhaib Atri,Mahdi Hammami,Ahmed Ben Mahmoud et al.
Souhaib Atri et al.
Introduction: Ileocecal resection (ICR) is the most common procedure for primary Crohn's disease. While outcomes of ICR have been extensively studied in Europe and North America, data from North Africa remains scarce. Thi...
Comparative effectiveness of adalimumab versus infliximab in children with Crohn's disease: real-world data from the prospective PIBD-SETQuality inception cohort study [0.03%]
利塞昔单抗和阿达木单抗治疗克罗恩病儿童的疗效比较：前瞻性PIBD-SETQuality初始队列研究的真实世界数据
Stephanie A Vuijk,Renz C W Klomberg,Eva Katgert et al.
Stephanie A Vuijk et al.
Background: Infliximab and adalimumab are effective anti-tumor necrosis factor (anti-TNF) therapies for the treatment of pediatric Crohn's disease (CD). The aim of this study was to compare the effectiveness of infliximab...
Bowel urgency in ulcerative colitis is associated with clinical endpoints, health-related quality of life, and biomarkers: data from the etrasimod ELEVATE UC 52 trial [0.03%]
溃疡性结肠炎急迫便与临床终点、健康相关生活质量及生物标志物的关系：etrasimod ELEVATE UC 52试验数据
Marla C Dubinsky,Erica R Cohen,Peter M Irving et al.
Marla C Dubinsky et al.
Background: Bowel urgency (BU) is a disruptive ulcerative colitis (UC) symptom. Etrasimod, a sphingosine 1-phosphate (S1P)1,4,5 receptor modulator, improved BU in the ELEVATE UC clinical program. ...
Induction-phase infliximab monitoring accelerates time to remission in pediatric IBD: a retrospective cohort study [0.03%]
英夫利昔单抗诱导期监测可加速儿童炎症性肠病的缓解：一项回顾性队列研究
Nicholas Iovino,Samantha R Paglinco,Mahmoud Abdel-Rasoul et al.
Nicholas Iovino et al.
Background: In pediatric inflammatory bowel disease (IBD), the optimal timing to begin therapeutic drug monitoring (TDM) of infliximab (IFX) is unclear. We hypothesized that TDM during induction of IFX improves clinical o...
Nutrition management and self-perceived relapse triggers in patients with inflammatory bowel disease: results from the 3R web-based survey [0.03%]
炎症性肠病患者营养管理和自我感知的复发诱因：一项基于网络的3R调查的结果
Motohiro Esaki,Takayuki Matsumoto,Fumihito Hirai et al.
Motohiro Esaki et al.
Background and aims: Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), requires long-term management. Besides pharmacotherapy, nutritional care is considered to be importan...
Effective endoscopy reporting in inflammatory bowel disease: a trainee's guide [0.03%]
有效报告炎症性肠病内镜检查：一份培训指南
Kofi Clarke,Matthew D Coates
Kofi Clarke
Disability among Palestinian patients with inflammatory bowel disease: evaluation using the IBD Disk and identification of associated factors [0.03%]
使用IBD Disk评估巴勒斯坦炎症性肠病患者的残疾状况及识别相关因素
Ahmed Quraish,Ro&#x;ya Khanfar,Karmil Kharouf et al.
Ahmed Quraish et al.
Background: Inflammatory bowel disease (IBD) can substantially impair daily functioning, yet disability prevalence and determinants remain underexplored in Palestine. This study aimed to assess the prevalence of IBD-relat...
Impact of pediatric versus adult diagnosed inflammatory bowel disease on achievement of health care autonomy in emerging adults: a cross-sectional study [0.03%]
儿童期与成人期诊断的炎症性肠病对新兴成人实现医疗自主权的影响：一项横断面研究
Allison Bihari,Cynthia H Seow,Eytan Wine et al.
Allison Bihari et al.
Introduction: Emerging adulthood (ages 18-25) involves significant changes, made more challenging for those with inflammatory bowel disease (IBD), especially when transitioning from pediatric to adult care. Research has f...